Difference between revisions of "Usability Testing Guide"

From OpenEMR Project Wiki
Line 4: Line 4:


==Task 1: Update Prostate Cancer Screening rule to explain the rule's usage of patient's biologic patient's sex.==
==Task 1: Update Prostate Cancer Screening rule to explain the rule's usage of patient's biologic patient's sex.==
:* Edit demographics for 'Ed Smith'
:* The OpenEMR internal CDR is missing source attribute information on how it's Prostate Cancer Screening rule is using the patient's biological birth sex information in its rule calculations. You need to update the source attribute information for this rule to explain that the sex data point is used to determine if the patient is male and should be screened for prostate cancer. This will help clinicians make informed decisions as to the efficacy and safety of the rule.
::* Gender Identity choose 'Identifies as Male'
::*j
::* Sexual Orientation choose 'Straight or Heterosexual'
::* DOB change to '1968-12-30'
:* After saving above demographic changes, clinical decision support will display window with new due reminders based off age (including Colon Cancer Screening).
<br>
<br>



Revision as of 06:38, 27 October 2024

Usability testing scenario

  • Ed Smith is a patient in the user's clinic. In this scenario, the user will 'update Prostate Cancer Screening rule to explain the rule's usage of patient's biologic patient's sex', 'provide rule feedback on incorrect application of Pap Smear rule for Ed Smith due to incorrect biological sex', and 'update 3rd party decision support intervention source attribute field information'.


Task 1: Update Prostate Cancer Screening rule to explain the rule's usage of patient's biologic patient's sex.

  • The OpenEMR internal CDR is missing source attribute information on how it's Prostate Cancer Screening rule is using the patient's biological birth sex information in its rule calculations. You need to update the source attribute information for this rule to explain that the sex data point is used to determine if the patient is male and should be screened for prostate cancer. This will help clinicians make informed decisions as to the efficacy and safety of the rule.
  • j


Task 2: Provide rule feedback on incorrect application of Pap Smear rule for Ed Smith due to incorrect biological sex.

  • Add prescription for 'Ed Smith'
  • Lipitor 20mg tabs Per Oris q.d. with quantity of 30


Task 3: Update 3rd party decision support intervention source attribute field information.

  • Add Implantable Device for 'Ed Smith'
  • UDI is (01)00889095205923(11)141231(17)150707(10)A213B1(21)1234